AntalGenics is a biotechnological company focused on the discovery and development of new bioactive molecules for biomedical and dermocosmetic applications

 

AntalGenics is a biotechnological company focused on the discovery and development of new bioactive molecules for biomedical and dermocosmetic applications

 

DISCOVERY

AntalGenics focuses its R&D program on the discovery, validation and development of bioactive molecules for biomedicine and dermocosmetic area.

QUALITY

AntalGenics aims is to become a quality reference in the development and commercialization of bioactive topical applications.

INTERMEDIATION

AntalGenics acts as an intermediator and translator between the research world and the productive sector.

AntalGenics’ R&D program is located in the last research stage, the translation into the society, transforming its scientific results and technology into fully exploitable products or services for third parties.

licensed cosmeceutical products currently on the market

patents of new analgesic and cosmetic molecules

years of experience

Want to know more?

 

CHECK OUR R&D STRATEGIES

MISSION

To discover and develop innovative analgesic leads in the field of sensory neurobiology and pain transduction.

VISION

To generate precise, novel analgesic therapeutics for the treatment of pain, inflammatory skin disorders and sensitive skin.

STRATEGY

To develop internal R&D projects with validated targets by focusing on peripheral mechanisms and topical treatments.

To license out leads upon Phase II/III clinical trials.

To license in novel technologies from public research.

To offer to third parties specifically tailored R&D projects by acting as an Externalized R&D Organization (ERDO).

Interested?

 

CHECK OUR SERVICES

Founded in February 2015, AntalGenics is located in the Scientific Park from the University Miguel Hernández in Elche, Alicante, Spain